Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer

Completed · Phase 3

Conditions studied: Breast Neoplasms

In brief

This is a phase 3 randomized trial evaluating the anti-tumor activity and safety of sunitinib combined with docetaxel versus docetaxel, administered as first-line treatment, in patients with unresectable locally recurrent or metastatic breast cancer.

Key facts

Study ID

NCT00393939

Run by

Pfizer

People needed

594

Starts

2007-02-01

Expected to finish

2011-07-01

Last updated by the study team

2012-07-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Breast cancer with evidence of unresectable locally recurrent, or metastatic disease
• Her-2 negative tumors

You may not qualify if…

• Patients for whom docetaxel is contraindicated
• Clinical presentation of inflammatory carcinoma with no other measurable disease

Where it is running

• Pfizer Investigational Site — Shreveport, Louisiana, United States
• Pfizer Investigational Site — Beaumont, Texas, United States
• Pfizer Investigational Site — Burleson, Texas, United States
• Pfizer Investigational Site — Cleburne, Texas, United States
• Pfizer Investigational Site — Fort Worth, Texas, United States
• Pfizer Investigational Site — Mineral Wells, Texas, United States
• Pfizer Investigational Site — Weatherford, Texas, United States
• Pfizer Investigational Site — La Plata, Buenos Aires, Argentina
• Pfizer Investigational Site — Pergamino, Buenos Aires, Argentina
• Pfizer Investigational Site — Burnos Aires, Argentina
• Pfizer Investigational Site — Tweed Heads, New South Wales, Australia
• Pfizer Investigational Site — Redcliffe, Queensland, Australia
• Pfizer Investigational Site — Adelaide, South Australia, Australia
• Pfizer Investigational Site — Brighton, Victoria, Australia
• Pfizer Investigational Site — Malvern, Victoria, Australia
• Pfizer Investigational Site — Ringwood East, Victoria, Australia
• Pfizer Investigational Site — Perth, Western Australia, Australia
• Pfizer Investigational Site — Salzburg, Austria
• Pfizer Investigational Site — Vienna, Austria
• Pfizer Investigational Site — Vienna, Austria
• Pfizer Investigational Site — Vienna, Austria
• Pfizer Investigational Site — Brasschaat, Belgium
• Pfizer Investigational Site — Brussels, Belgium
• Pfizer Investigational Site — Verviers, Belgium
• Pfizer Investigational Site — Berkely, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.